• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>ICO

ICO

  1. Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation of AmiKet

    Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation of AmiKet

  2. Research and Markets: Wet (Neovascular / Exudative) Macular Degeneration Therapeutics Pipeline Review 2015: 41 Companies

    Research and Markets: Wet (Neovascular / Exudative) Macular Degeneration Therapeutics Pipeline Review 2015: 41 Companies

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.